You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

82 Results
Guidelines and Advice
Status: Current
ID: 8-6
Version: 2
Aug 2018
Guidelines and Advice
Status: In-Review
ID: 12-12-2
Version: 2
Nov 2018
Guidelines and Advice
Status: Archived
ID: 15-11
Version: 3
Jan 2018
Guidelines and Advice
Status: Current
ID: 17-6
Version: 2
May 2018
Guidelines and Advice
Status: Current
ID: GL-C50-06
Jan 2018
Guidelines and Advice
Status: Archived
ID: 43096
Feb 2018
Drug
Other Name(s): Yondelis® (Janssen)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2018
Drug
Other Name(s): Mutamycin® (generic brand available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2018
Drug
Other Name(s): Novantrone® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2018
Drug
Other Name(s): Halaven® (Eisai)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jan 2018
Regimen
Cancer Type:
Gynecologic, 
Germ Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
CISplatin,
ifosfamide,
etoposide,
mesna
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2018
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024

Pages